share_log

Pacer Advisors Inc. Decreases Stock Holdings in Option Care Health, Inc. (NASDAQ:OPCH)

Defense World ·  Dec 31, 2022 04:41

Pacer Advisors Inc. decreased its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH – Get Rating) by 97.8% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 3,708 shares of the company's stock after selling 161,292 shares during the quarter. Pacer Advisors Inc.'s holdings in Option Care Health were worth $117,000 as of its most recent SEC filing.

A number of other hedge funds also recently bought and sold shares of OPCH. Victory Capital Management Inc. raised its stake in shares of Option Care Health by 2,435.1% in the second quarter. Victory Capital Management Inc. now owns 1,274,994 shares of the company's stock valued at $35,432,000 after acquiring an additional 1,224,700 shares during the period. HMS Capital Management LLC purchased a new stake in shares of Option Care Health in the third quarter valued at $437,000. Loomis Sayles & Co. L P raised its stake in shares of Option Care Health by 65.1% in the first quarter. Loomis Sayles & Co. L P now owns 2,676,475 shares of the company's stock valued at $76,440,000 after acquiring an additional 1,055,722 shares during the period. Coliseum Capital Management LLC purchased a new stake in shares of Option Care Health in the second quarter valued at $10,840,000. Finally, Jag Capital Management LLC purchased a new stake in shares of Option Care Health in the second quarter valued at $243,000. Hedge funds and other institutional investors own 97.63% of the company's stock.

Get Option Care Health alerts:

Option Care Health Trading Down 1.0 %

NASDAQ OPCH opened at $30.09 on Friday. The company's 50-day moving average price is $30.25 and its 200-day moving average price is $31.08. The company has a current ratio of 1.62, a quick ratio of 1.22 and a debt-to-equity ratio of 0.79. The stock has a market cap of $5.47 billion, a PE ratio of 30.70, a PEG ratio of 2.80 and a beta of 1.19. Option Care Health, Inc. has a 12 month low of $21.32 and a 12 month high of $35.87.

Option Care Health (NASDAQ:OPCH – Get Rating) last posted its quarterly earnings results on Thursday, October 27th. The company reported $0.21 EPS for the quarter, hitting analysts' consensus estimates of $0.21. The firm had revenue of $1.02 billion for the quarter, compared to analysts' expectations of $994.38 million. Option Care Health had a net margin of 4.64% and a return on equity of 11.80%. Equities research analysts forecast that Option Care Health, Inc. will post 0.79 earnings per share for the current year.

Insiders Place Their Bets

In other Option Care Health news, Director R Carter Pate sold 1,928 shares of the stock in a transaction dated Monday, October 3rd. The shares were sold at an average price of $31.97, for a total transaction of $61,638.16. Following the transaction, the director now directly owns 95,530 shares in the company, valued at approximately $3,054,094.10. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 0.22% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

Separately, Barrington Research increased their target price on shares of Option Care Health from $37.00 to $38.00 and gave the company an "outperform" rating in a research note on Friday, October 28th.

Option Care Health Profile

(Get Rating)

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.

See Also

  • Get a free copy of the StockNews.com research report on Option Care Health (OPCH)
  • MarketBeat: Week in Review 12/26 – 12/30
  • The Dogs Of Tech: It's Time For A Bite Of These Stocks
  • Does This Acquisition Make Microsoft a Bear Market Buy?
  • Is Kintara Therapeutics A Hidden Gem?
  • Should You Warm up to Generac Stock for the Winter?

Want to see what other hedge funds are holding OPCH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Option Care Health, Inc. (NASDAQ:OPCH – Get Rating).

Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment